These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12105259)

  • 21. Perindopril attenuates renal tubulointerstitium injury by inhibiting scavenger receptor A over-expression in diabetic rats.
    Sun L; Wen JH; Sun HL; Shu XC; Hu F; Yin DC; Yang Q; Zeng YJ; Sun Y; Liu L
    J Endocrinol Invest; 2012 May; 35(5):511-5. PubMed ID: 21765240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE inhibition salvages the visual loss caused by diabetes.
    Bui BV; Armitage JA; Tolcos M; Cooper ME; Vingrys AJ
    Diabetologia; 2003 Mar; 46(3):401-8. PubMed ID: 12687339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
    Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
    J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli.
    Kawachi H; Koike H; Kurihara H; Sakai T; Shimizu F
    J Am Soc Nephrol; 2003 Jan; 14(1):46-56. PubMed ID: 12506137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of human nephrin mRNA in diabetic nephropathy.
    Toyoda M; Suzuki D; Umezono T; Uehara G; Maruyama M; Honma M; Sakai T; Sakai H
    Nephrol Dial Transplant; 2004 Feb; 19(2):380-5. PubMed ID: 14736962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.
    Doublier S; Salvidio G; Lupia E; Ruotsalainen V; Verzola D; Deferrari G; Camussi G
    Diabetes; 2003 Apr; 52(4):1023-30. PubMed ID: 12663475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy.
    Yuan H; Takeuchi E; Taylor GA; McLaughlin M; Brown D; Salant DJ
    J Am Soc Nephrol; 2002 Apr; 13(4):946-956. PubMed ID: 11912254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
    Kawachi H; Suzuki K; Miyauchi N; Hashimoto T; Otaki Y; Shimizu F
    Clin Exp Nephrol; 2009 Aug; 13(4):275-280. PubMed ID: 19266252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
    Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy.
    Saran AM; Yuan H; Takeuchi E; McLaughlin M; Salant DJ
    Kidney Int; 2003 Dec; 64(6):2072-8. PubMed ID: 14633129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
    Davis BJ; Johnston CI; Burrell LM; Burns WC; Kubota E; Cao Z; Cooper ME; Allen TJ
    Diabetologia; 2003 Jul; 46(7):961-71. PubMed ID: 12838387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
    Benigni A; Colosio V; Brena C; Bruzzi I; Bertani T; Remuzzi G
    Diabetes; 1998 Mar; 47(3):450-6. PubMed ID: 9519753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
    Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
    J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.
    Marotta F; Harada M; Dallah ED; Yadav H; Solimene U; Di Lembo S; Minelli E; Jain S; Chui DH
    J Biol Regul Homeost Agents; 2010; 24(1):41-9. PubMed ID: 20385070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
    Sugimoto H; Shikata K; Wada J; Horiuchi S; Makino H
    Diabetologia; 1999 Jul; 42(7):878-86. PubMed ID: 10440132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.